Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
253.00    -7.00 (-2.69%)
Bid:
253.00
Ask:
262.00
Spread: 9.00 (3.557%)
Market Cap: £226.58m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Share repurchase programme

27 Feb 2025 07:00

RNS Number : 5883Y
Wilmington PLC
27 February 2025
 

 

27 February 2025

 

Wilmington plc

Share repurchase programme

 

Wilmington plc ("Wilmington" or the "Group") (LON: WILM), the provider of data, information, education and training services in the global Governance, Risk and Compliance (GRC) markets, announces today that it will today commence a share repurchase programme of its ordinary shares of 5 pence each (the "Ordinary Shares") up to a maximum consideration of £5 million to be executed by the Group's next Annual General Meeting, expected to be held in November 2025 (the "Repurchase Programme").

 

As announced at the Group's half year results, Wilmington has a strong balance sheet which allows it to invest across the business, both organically and inorganically. The Board has concluded that a repurchase programme provides a balanced approach for additional returns of capital to shareholder whilst it continues its strategic priority, being the active pursuit of opportunities to invest in accretive acquisitions.

 

Wilmington has entered into a non-discretionary arrangement with Numis Securities Limited, trading as Deutsche Numis, to conduct the Repurchase Programme on its behalf starting from today. Under these arrangements, Deutsche Numis will make trading decisions in relation to the buyback of the Group's ordinary shares of 5 pence each independently of the Group within the programme terms and pre-set parameters, including in the case of any purchases made during closed periods.

 

Any purchase of Ordinary Shares done in relation to this announcement will be executed in accordance with (i) the terms and parameters of Deutsche Numis' engagement; (ii) the relevant regulations, including the EU Market Abuse Regulation (596/2014), the Commission Delegated Regulation (2016/1052), in each case as such legislation forms part of retained EU law (as defined in the EU (Withdrawal) Act 2018), and Chapter 12 of the Financial Conduct Authority's Listing Rules and (iii) the Group's general authority to make market purchases of Shares as approved by shareholders at the AGM held on 28th November 2024. There may be circumstances where the Group conducts share repurchases such that they exceed 25 per cent of the average daily volume in Ordinary Shares for the 20 trading days prior to the share repurchase.

 

The Group will announce any market repurchase of ordinary shares no later than 7.30am on the business day following the calendar day on which the repurchase occurred. Ordinary shares purchased under the Repurchase Programme will either be cancelled or held in treasury.

 

The Group confirms that it currently has no unpublished price sensitive information.

 

For further information, please contact:

Wilmington plc 020 7490 0049

Guy Millward, Chief Financial Officer

 Meare Consulting 07990 858548

Adrian Duffield

 Notes to Editors

 

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs over 650 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCTFMFTMTMTBFA
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.